IRIS
GROSA, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.216
NA - Nord America 3.724
AS - Asia 2.132
SA - Sud America 271
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 1
Totale 10.406
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.652
RU - Federazione Russa 895
IE - Irlanda 764
CN - Cina 635
SG - Singapore 607
SE - Svezia 535
DE - Germania 521
IT - Italia 512
UA - Ucraina 358
HK - Hong Kong 290
VN - Vietnam 265
FI - Finlandia 216
BR - Brasile 208
FR - Francia 149
GB - Regno Unito 114
IN - India 114
KR - Corea 49
CA - Canada 38
TR - Turchia 35
BE - Belgio 32
IR - Iran 29
EE - Estonia 25
AR - Argentina 24
MX - Messico 23
BD - Bangladesh 20
CZ - Repubblica Ceca 18
ES - Italia 18
JP - Giappone 17
IQ - Iraq 15
PL - Polonia 15
ZA - Sudafrica 12
EC - Ecuador 11
BJ - Benin 10
ID - Indonesia 10
LT - Lituania 10
PK - Pakistan 10
EU - Europa 9
MA - Marocco 8
NL - Olanda 8
CL - Cile 7
PY - Paraguay 5
UZ - Uzbekistan 5
VE - Venezuela 5
AT - Austria 4
BG - Bulgaria 4
CH - Svizzera 4
CO - Colombia 4
EG - Egitto 4
PE - Perù 4
SA - Arabia Saudita 4
TH - Thailandia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
ET - Etiopia 3
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
MD - Moldavia 3
PH - Filippine 3
TN - Tunisia 3
BO - Bolivia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
JO - Giordania 2
KE - Kenya 2
NP - Nepal 2
RO - Romania 2
SV - El Salvador 2
AL - Albania 1
AO - Angola 1
BW - Botswana 1
CG - Congo 1
DM - Dominica 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
SN - Senegal 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 10.406
Salva come PNG Salva come JPEG
Città #
Dublin 764
Jacksonville 588
San Jose 328
Hong Kong 289
Dearborn 280
Chandler 261
Singapore 235
Beijing 221
Ashburn 193
Wilmington 154
Ann Arbor 147
Moscow 128
Piemonte 128
Lawrence 100
Los Angeles 100
Princeton 100
Lauterbourg 82
Ho Chi Minh City 81
San Mateo 81
Andover 68
Munich 66
Hanoi 63
Council Bluffs 53
Buffalo 46
Seoul 45
New York 43
Philadelphia 39
Woodbridge 39
Bremen 36
Helsinki 35
Boardman 32
Brussels 32
Milan 32
Houston 27
São Paulo 26
Hefei 24
Orem 24
Santa Clara 24
Guangzhou 21
Frankfurt am Main 20
Nanjing 20
Chennai 19
Dallas 17
Kocaeli 17
Toronto 17
Brno 16
Monmouth Junction 15
Rome 15
Redondo Beach 14
Tokyo 14
Hangzhou 12
Tianjin 12
Warsaw 12
Norwalk 11
Sacramento 11
Torino 11
Chicago 10
Cotonou 10
Da Nang 10
Denver 10
Haiphong 10
Montreal 10
Nanchang 10
Seattle 10
Turku 10
Ankara 9
Boston 9
Brasília 9
Brooklyn 9
Jinan 9
London 9
Novara 9
Stockholm 9
Zhengzhou 9
Dong Ket 8
Fairfield 8
Falkenstein 8
Johannesburg 8
Mexico City 8
Poplar 8
Shenyang 8
Zanjan 8
Amsterdam 7
Ardabil 7
Biên Hòa 7
Chengdu 7
Kunming 7
Leawood 7
Manchester 7
Nuremberg 7
Atlanta 6
Baghdad 6
Guarulhos 6
Mumbai 6
Phoenix 6
Salerno 6
San Francisco 6
Shanghai 6
Asti 5
Boltiere 5
Totale 5.637
Salva come PNG Salva come JPEG
Nome #
ELEMENTI DI GALENICA CON ESERCIZI DI TARIFFAZIONE 214
Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents 178
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 168
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 166
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group 165
Preparazioni galeniche Esercizi di tariffazione secondo la nuova TNM 164
A Concise Synthesis of Pyrazole Analogues of Combretastatin A1 as Potent Antitubulin Agents 160
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 160
Inhibitors of Nicotinamide Phosphoribosyltransferase, compositions, products and uses thereof. 159
Are 1,4- and 1,5-Disubstituted 1,2,3-Triazoles Good Pharmacophoric Groups? 155
Metabolic fate of combretastatin A-1: LC-DAD-MS/MS investigation and biological evaluation of its reactive metabolites 153
Development and validation of a stability-indicating HPLC-UV method for the determination of Thiocolchicoside and its degradation products 147
La spettrometria di massa negli studi di stabilità dei farmaci 143
CHEMICAL STABILITY STUDIES OF PROPARGYLAMINE-CONTAINING DRUGS 138
Biological effects of combined resveratrol and vitamin D3 on ovarian tissue 137
Identification of a Potent Phosphoinositide 3-Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its Prodrugs 135
DETERMINAZIONE HPLC SIMULTANEA DELLA GUAIFENESINA E DEL METILE E PROPILE p-IDROSSIBENZOATO IN UNA FORMULAZIONE LIQUIDA 132
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 130
Development and validation of a stability-indicating LC–UV method for the determination of pantethine and its degradation product based on a forced degradation study 129
FORCED DEGRADATION STUDY OF TIOCOLCHICOSIDE: HPLC-MS CHARACTERIZATION OF DEGRADATION PRODUCTS 128
Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues 127
New insights in oxybutynin chemical stability: Identification in transdermal patches of a new impurity arising from oxybutynin N-oxide rearrangement 124
CHEMICAL STABILITY STUDIES OF PROPARGYLAMINE CONTAINING-DRUGS 123
Elementi di galenica con esercizi di tariffazione 122
Development and validation of a stability-indicating HPLC-UV method for the determination of alizapride and its degradation products 119
New insights in the metabolism of oxybutynin: evidence of N-oxidation of propargylamine moiety and rearrangement to enaminoketone 119
2,3-epoxy-10-aza-10,11-dihydrosqualene, an high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase 118
A new approach in the synthesis of immunotoxins ribosome inactivating protein non covalently bound to monoclonal antibody 115
FORCED DEGRADATION STUDY OF DOXOFYLLINE: HPLC-MS CHARACTERIZATION OF DEGRADATION PRODUCTS IN BULK DRUG 113
DEVELOPMENT AND VALIDATION OF HPLC-UV STABILITY INDICATING METHOD FOR THE DETERMINATION OF THIOCOLCHICOSIDE AND ITS DEGRADATION PRODUCTS IN PHARMACEUTICAL DOSAGE FORM 113
Synthesis of a squalenoid oxaziridine and other new classes of squalene derivatives, as inhibitors of sterol biosynthesis 112
Azasqualene alcohol and derivatives new selective inhibitors of 2,3-oxidosqualene cyclase 112
2,3,4,5-tetrahydroxy-5- (4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling 112
3-carboxy-4-nitrophenyl-dithio-1,1',2-trisnorsqualene: a site-directed inactivator of yeast oxidosqualene cyclase 112
Troxerutin, a mixture of O-hydroxyethyl derivatives of the natural flavonoid rutin: Chemical stability and analytical aspects 112
Synthesis and antibronchospastic activity of theophylline thioacetal derivatives 111
Development and validation of a solid-phase extraction and gas chromatography–tandem mass spectrometry method for the determination of isopropyl-9H-thioxanthen-9-one in carton packaged milk 108
Semicarbazide Hydrochloride as Impurity in Drug Substances: a Validated LC-DAD-UV Method for Its Determination in Carbazochrome and Carbazochrome Sodium Sulfonate 107
In vitro metabolism of 1,3-dioxane, 1,3-oxathiolane and 1,3-dithiane derivatives of theophylline: a structure-metabolism correlation study 105
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan 103
2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors 102
FORCED DEGRADATION OF DOXOFYLLINE IN BULK DRUG: IDENTIFICATION OF THREE DEGRADATION PRODUCTS 102
IN VITRO METABOLISM STUDY OF ISOPROPYL-9H-THIOXANTHEN-9-ONE (ITX) IN RAT LIVER MICROSOMES 102
In vitro metabolism of Bumetanide 101
LC-ESI-MS/MS CHARACTERIZATION OF DEGRADATION PRODUCTS OF TROPANE ALKALOIDS IN BELLADONNA DRY EXTRACT 101
Kinetics of ABC-99 in the rat 99
Thiol-modifying inhibitors for understanding squalene cyclase function 99
Doxofylline in rat brain in relation to locomotor activity - Drug Metabolism and Disposition 97
An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline 96
Drug design based on biosynthetic studies: synthesis, biological activity and kinetics of new inhibitors of 2,3-oxido squalene cyclase and squalene epoxidase 96
Forced degradation study of thiocolchicoside: Characterization of its degradation products 96
A new "solid phase" procedure to synthetize immunotoxins 95
Role of chocolate consumption in the inflammatory pathway: a proteomic approach 94
New Hyaluronic Acid from Plant Origin to Improve Joint Protection—An In Vitro Study 93
Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis 93
In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes 92
In vitro metabolism study of 2-isopropyl-9H-thioxanthen-9-one (2-ITX) in rat and human: evidence for the formation of an epoxide metabolite 92
2-aza-2,3-dihydrosqualene:biodistribution and pharmacokinetic properties in mice 91
SIMULTANEOUS DETERMINATION OF SEROTONIN AND CATECHOLAMINES IN RAT BRAIN BY LC-MS/MS 91
Metabolic Fate of the Isocyanide Moiety: Are Isocyanides Pharmacophore Groups Neglected by Medicinal Chemists? 91
Synthesis and biological activity of 19-azasqualene 2,3-epoxide as inhibitor of 2,3-oxidosqualene cyclase 89
FORCED DEGRADATION STUDY OF OXYBUTYNIN: NEW INSIGHTS FROM LC-MS/MS ANALYSIS ON ITS CHEMICAL STABILITY 89
LC-MS CHARACTERIZATION OF THE IN VITRO METABOLITES OF ALIZAPRIDE 88
IN VITRO METABOLIC FATE OF COMBRETASTATIN A-4: EVIDENCE FOR THE FORMATION OF A SULPHATE CONJUGATE METABOLITE 87
In vitro metabolism of 2-(5-ethylpyridin-2-yl)benzimidazole 87
IN VITRO METABOLISM OF ALIZAPRIDE: EVIDENCE FOR THE FORMATION OF ACROLEIN IN RAT LIVER MICROSOMES 85
Synthesis of squalenoid acetylenes and allenes, as inhibitors of squalene epoxidase 85
Metabolism of 4-(3-cyclohexylpropionyl)-1-(2-ethoxyphenyl)piperazine (D-16120) by rat liver microsomes 85
Metabolism of Doxophylline by rat liver microsomes 85
In vitro metabolism of N-picolyl-3,5-dimethylbenzamides 83
In vitro metabolic fate of alizapride: evidence for the formation of reactive metabolites based on liquid chromatography-tandem mass spectrometry 83
IN VITRO, IN VIVO METABOLISM STUDY OF COMBRETASTATIN A-4 IN RAT AND HUMAN 83
Solubilization and identification of essential functional groups of Candida albicans oxidosqualene cyclase 82
Nitroanilines are the reduction products of benzofuroxan system by oxyhemoglobin (HbO22+) 82
HPLC DETERMINATION OF DOXOFYLLINE AND ITS DEGRADATION PRODUCTS IN DRUG SUBSTANCE: DEVELOPMENT AND VALIDATION 82
Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4. Drug Metabolism and Disposition 81
Synthesis and biological activity of a squalenoid maleimide and other classes of squalene derivatives as irreversible inhibitors of 2,3-oxidosqualene cyclase 79
In vitro metabolism of azasqualene derivatives and their effects on aminopyrine N-demethylase activity in rat liver microsomes 78
Metabolismo in vitro della 7-(3-acetil-1,3-tiazolidin-2-ilmetil)teofillina: solfossidazione diastereoselettiva 77
The Metabolic Fate of isoCombretastatin A-4 in Human Liver Microsomes: Identification, Synthesis and Biological Evaluation of Metabolites. 77
IN VITRO METABOLIC FATE OF COMBRETASTATIN A-4: EVIDENCE FOR THE FORMATION OF QUINONE METABOLITES 77
In vitro metabolism study of 2-isopropyl-9H-thioxanthen-9-one (2-ITX) in rat and human: Evidence for the formation of an epoxide metabolite 77
Metabolism of 1,1-dichloro-cis-diphenylcyclopropane by rat liver microsomes 77
The metabolic fate of the anti-Parkinsonian drug Budipine in rats 76
LC-ESI-MS/MS characterization of strophanthin-K 76
Pharmacokinetic of an antibody-ricin conjugate administered intraperitoneally to mice 75
NO-Donor 1,4-dihydropyridine analogues of Amlodipine 75
Thermolysis of 4-(2-azido-3-nitrophenyl)-1,4-dihydropyridines as sources of b-carboline derivatives and some related compounds 74
Toxin-targeted design for anticancer therapy - Part I. Synthesis and biological evaluation of new thioimidate heterobifunctional reagents 74
In vitro and in vivo phase II metabolism of combretastatin A-4: evidence for the formation of a sulphate conjugate metabolite 74
LC-MS CHARACTERIZATION OF IN VITRO METABOLISM OF COMBRETASTATIN A-4 73
Metabolism of 7-(1,3-thiazolidin-2-ylmethyl)theophylline by rat liver microsomes: evidence for a monooxygenase-dependent step in 1,3-thiazolidine ring cleavage 72
Lack of in vitro interactions using human liver microsomes between rabeprazole and anticancer drugs 71
Formation of lecithin-based microemulsions containing n-alkanol phosphocholines 71
Metabolism of 7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine (ABC-99) by rat liver microsomes: diastereoselective metabolism of the 1,3-dithiolane ring 71
LC-MS CHARACTERIZATION OF K-STROPHANTHIN 70
LC-MS ANALYSIS OF BITTER PRINCIPLES OF ARTEMISIA ABSINTHIUM L 67
In vivo metabolism of the anti-inflammatory agent 2-(5-ethyl-pyridin-2-yl)benzimidazole (KB-1043) 67
Simultaneous, stability indicating, HPLC-DAD determination of guaifenesin and methyl and propyl-parabens in cough syrup 66
IN VITRO METABOLISM STUDY OF ISOPROPYL-9H-THIOXANTHEN-9-ONE (ITX) IN RAT AND HUMAN LIVER MICROSOMES 65
Totale 10.386
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.363
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 0 0 57
2021/2022928 62 27 161 144 46 5 79 20 50 65 91 178
2022/20231.713 114 53 80 71 145 187 48 110 794 8 56 47
2023/2024431 47 33 34 7 78 3 98 14 0 14 36 67
2024/20251.038 33 20 43 24 40 90 133 54 276 118 31 176
2025/20263.509 165 119 259 515 341 270 474 614 226 312 174 40
Totale 10.502